27 equity mutual funds offer over 25% CAGR in both 3 and 5 years. Have you added any to your portfolio?
Live Events
Around 27 equity mutual funds have offered over 25% CAGR in both the last three and five years. There were around 199 equity mutual funds that completed five years of existence in the market.Among these 27 schemes, the maximum schemes were from HDFC Mutual Fund. There were around five schemes from the fund house, followed by three each from Invesco Mutual Fund, Motilal Oswal Mutual Fund, and Nippon India Mutual Fund. Two schemes each from Bandhan Mutual Fund, Franklin Templeton Mutual Fund, and JM Mutual Fund. Seven other fund houses had one scheme each.Also Read | Over 260 debt mutual funds beat fixed deposits rate in 2 years. Should you switch? Bandhan Core Equity Fund and Bandhan Small Cap Fund offered over 25% CAGR in both the last three and five years. Edelweiss Mid Cap Fund offered 27.45% and 34.46% CAGR in the last three and five years, respectively.Mid and small cap funds from Franklin Templeton Mutual Fund - Franklin India Prima Fund and Franklin India Smaller Cos Fund - offered over 25% CAGR in the said horizons.Five schemes from HDFC Mutual Fund - HDFC ELSS Tax saver , HDFC Flexi Cap Fund, HDFC Focused 30 Fund, HDFC Mid-Cap Opportunities Fund, and HDFC Small Cap Fund - featured in the list of equity schemes that have offered over 25% CAGR in the said periods.HSBC Value Fund gave 25.59% and 31.32% CAGR in the last three and five years respectively. Three funds from Invesco Mutual Fund - Invesco India Large & Mid Cap Fund, Invesco India Midcap Fund, and Invesco India Smallcap Fund gained over 25% in the mentioned time periods.JM Flexicap Fund and JM Value Fund delivered over 25% CAGR in the same time periods. Mahindra Manulife Mid Cap Fund, the only scheme from Mahindra Manulife Mutual Fund, featured in the list.Three schemes - Motilal Oswal ELSS Tax Saver Fund, Motilal Oswal Large & Midcap Fund, and Motilal Oswal Midcap Fund - offered CAGR over 25% in the said time periods. Three schemes from Nippon India Mutual Fund were there in the list of schemes that gave over 25% CAGR in both the horizons. Quant Small Cap Fund offered 26.33% and 49.62% CAGR in the last three and five years, respectively. SBI Long Term Equity Fund, the oldest ELSS fund, offered 27.72% and 30.30% CAGR in the last three and five years, respectively.Also Read | HDFC Bank, Eternal among stocks bought and sold by SBI Mutual Fund in April Sundaram Mid Cap Fund offered 26.92% and 31.28% CAGR in the last three and five years, respectively.Among these 27 funds, Motilal Oswal Midcap Fund has offered the highest CAGR of around 31.93% in the last three years, whereas within the same universe, Quant Small Cap Fund has offered the highest CAGR of 49.62% in the last five years.We considered all equity mutual fund categories. We considered regular and growth options. We calculated the CAGR over the last three and five years.Note, the above exercise is not a recommendation. The exercise was done to find which equity schemes have offered over 25% CAGR in the last three and five years both. One should not make investment or redemption decisions based on the above exercise.One should always invest based on their risk appetite, investment horizon, and goals.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
3 days ago
- Business Standard
Motilal Oswal MF launches BSE 1000 Index Fund: Here's all you need to know
Motilal Oswal BSE 1000 Index Fund: Motilal Oswal Mutual Fund has launched its Motilal Oswal BSE 1000 Index Fund, an open-ended scheme tracking BSE 1000 Total Return Index. The new fund offer (NFO) will open for subscription today, June 5, 2025, and close on Thursday, June 19, 2025. The fund provides broad-based exposure to India's equity markets by tracking the BSE 100 Total Return Index, which covers around 94 per cent of the country's listed market capitalisation. It includes companies across large, midcap, smallcap, and micro-cap segments, representing diverse sectors and industries. The index offers a mix of established companies as well as fast-growing smaller firms from 22 different sectors. To reduce concentration risk, the top 10 stocks are capped at around 33 per cent of the total weight. It also includes micro-cap companies, whose market size and trading activity have grown from 5 times and 14 times, respectively, over the last five years. The index is passively managed, based on free-float market value, and is rebalanced twice a year. According to the Scheme Information Document (SID), the scheme aims to provide returns that, before expenses, correspond to the total returns of the securities as represented by BSE 1000, subject to tracking errors. However, there can be no assurance or guarantee that the investment objectives of the scheme will be achieved. According to SID, if the units are redeemed on or before 15 days from the day of allotment, an exit load of 1 per cent will be charged. However, no exit load will be charged if units are redeemed after 15 days from the date of allotment. According to the riskometer, the principal invested in the scheme will be at very high risk. ALSO READ | Swapnil Mayekar, Dishant Mehta, and Rakesh Shetty are the designated fund managers for the schemes. Pratik Oswal, chief of passive business at Motilal Oswal Asset Management Company (MOAMC), said that this fund provides a diversified exposure to India's corporate sector and is a natural evolution for investors seeking a passive investment option. "As pioneers in passive investing, our goal is to offer simple, low-cost, and scalable investment options, and this launch aligns with that objective," he added. During the NFO and ongoing basis, investors can invest a minimum amount of ₹5,000 and in multiples of ₹1 thereafter. The minimum amount and frequency vary for investments through a Systematic Investment Plan (SIP). Motilal Oswal BSE 1000 Index Fund: Who should invest? According to the SID, the fund is suitable for investors seeking long-term capital growth and return that corresponds to the BSE 1000 Total Return Index, subject to tracking error. However, investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Time of India
3 days ago
- Time of India
Neither largecaps, nor smallcaps! India Inc's Q4 result season belongs to the middle order
Even as investors debate whether to chase largecap safety or smallcap thrill, Q4 earnings have quietly handed the trophy to a third contender—India Inc's middle-order. Midcaps have emerged as the surprise winners of the March quarter, delivering relatively better numbers across revenue, EBITDA, profit before tax and net profit. Domestic brokerage firm Motilal Oswal said within its universe, midcaps posted a robust 19% YoY PAT growth, beating not just estimates (10% higher than expected) but also the performance of both largecaps (+10%) and smallcaps (a disappointing –16%). The earnings season, once again, proves that resilience and growth are often found in the mid-ranks. Motilal data shows this wasn't a narrow performance. Midcap Metals clocked an 84% YoY jump in PAT, accounting for over a third of incremental profits. Public sector banks in the midcap universe delivered a 39% surge, driving nearly 50% of total PAT growth. Electronics manufacturing services (EMS) continued their hot streak, rising 70% YoY. The quality of results was notable, with widespread distribution of strong growth across several midcap sectors – in several cases better than the largecap counterparts, Motilal's Gautam Duggad said. Also read | Sensex will hit 1.5 lakh by 2030 & 3 lakh by 2035! Raamdeo Agrawal makes big prediction Other sectors that posted strong growth included Capital Goods (+30%), Consumer Durables (72%), and NBFCs – both lending (23%) & non-lending (36%). 'Comparatively, the mid-cap technology sector was subdued, posting a 12% YoY growth (est. 19%), but better than the large-cap peers – which is in line with our long-standing thesis that mid-cap IT is poised to grow structurally above the large-cap IT names,' he said. 'While overall earnings have been ahead of estimates (a welcome departure from the past 3 quarters' outcome of broad earnings misses), the Mid-cap segment has been an unexpected standout surprise – underlining its critical role in throwing up growth leaders for future – thus broadening the market's investable set of companies,' Duggad said. Market experts also point out that as the market capitalisation of midcaps has grown in the last 2-3 years, FIIs are also showing greater interest due to the liquidity factor. Valuations, however, are getting stretched, warns Trideep Bhattacharya, CIO-Equities, Edelweiss Mutual Fund. 'Mid and smallcaps are now trading at a 17–25% premium to their 10-year averages. So, the earnings momentum must continue. If growth lags, these stocks will be in the penalty box.' That calls for stock-picking discipline. 'Where there is a valuation premium, it must be matched with an earnings growth premium. The market is currently unforgiving of any mismatch,' Bhattacharya added. Still, Bhattacharya believes that midcaps can remain in favour for the right investor profile. 'For conservative investors, flexicap funds work. For moderate risk-takers, multicap funds. And for those with higher risk appetite and a 5–10 year horizon, midcap funds are ideal.' Dr. Joseph Thomas, Head of Research at Emkay Wealth Management, says both mid and smallcaps offer better value to the portfolio on a longer-term basis. 'This is because of two reasons. After the corrective downward movements seen in the last three to four months, the valuations are now at reasonable levels. The segment offers better growth and therefore, better price performance,' he said. In short, the earnings strength, sectoral diversity, and growing institutional participation make midcaps too important to ignore. Also read | Rs 15 lakh crore in net profit! India Inc's top 500 cos break records in FY25 despite downgrades ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
&w=3840&q=100)
Business Standard
4 days ago
- Business Standard
E-commerce giant Flipkart offloads 6% stake in ABFRL; sells 73 mn shares
Carlyle Group affiliate firm, C A Dawn Investments, on Wednesday sold its entire 10.20 per cent in Indegene for ₹1,447 crore BS Reporter Flipkart Investments on Wednesday offloaded 6 per cent stake in Aditya Birla Fashion & Retail Ltd (ABFRL) for ₹588 crore. The e-commerce giant sold 73.17 million shares at ₹80.32 apiece. Shares of ABFRL fell nearly 11 per cent in secondary market trading to end at ₹76.8. Carlyle Group affiliate firm exits Indegene Carlyle Group affiliate firm, C A Dawn Investments, on Wednesday sold its entire 10.20 per cent in Indegene for ₹1,447 crore. It sold nearly 24.5 million shares at ₹591 apiece. Shares of Indegene fell 4.7 per cent to end at ₹590. Founder Kunhikannan sells 1.76% in Kaynes Ramesh Kunhikannan, founder, Kaynes Technology on Wednesday divested his 1.76 per cent stake in the firm. He sold 11.25 million shares at ₹5,551 apeice to raise ₹623 crore. Shares of Kaynes fell about a per cent to close at ₹5,730 crore. BS reporters Motilal Oswal Mutual Fund (MF) launched the first passive fund tracking the BSE 1000 index. The scheme Motilal Oswal BSE 1000 Index Fund, representing top 1000 listed companies offers exposure to about 94 per cent of the country's listed market capitalisation. The index at present has firms across 22 sectors. The top-10 stock weight is capped at 33 per cent to reduce concentration risk. Motilal Oswal is also in the process of finalising its plan to launch a scheme under the newly-introduced specialised investment fund (SIF) category in the next 6 months. Sekhmet Pharma appoints Santosh Mahil MD & CEO Private equity consortium led by PAG Sekhmet Pharmaventures has appointed Santosh Kumar Mahil (pictured) as the managing director (MD) and chief executive officer (CEO). Sekhmet is an investment platform that helps India's next generation of active pharmaceutical ingredient (API) companies. Mahil has nearly three decades of experience, having held leadership roles at Lupin, USV, Unichem, and Shilpa Medicare. BS reporter
